trs005
zhejiang teruisi biopharmaceuticals
['trs005']
join #esmo22 for the latest clinical trial update on #non-hodgkin #lymphoma a phase i study of trs005: an anti-cd20-mmae adc in rel/ref b-cell nhl
abs 6180 10 sept #meded #lymsm 
Independent, international experts in hematology and oncology, creating educational programmes on #lymsm and #mmsm.

#MedEd #oncology #hematology